Physician profile
Alexander Ross Webb
NPI 1174143275
$3,360.19
in general payments reported to CMS, 2019-2025
8 companies · $3,238 in 2025
The $3,238 reported for 2025 was more than what 77% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $122 · 2025: $3,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,675 · Grant: $1,500 · Travel and Lodging: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,675.19 |
| Grant | $1,500.00 |
| Travel and Lodging | $185.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,020.88 | 2025 | Infuse Bone Graft, Infinity Occipitocervical Upper Thoracic System, Cd Horizon Spinal System |
| Globus Medical, INC. | $387.46 | 2025 | Xlif, Alif, Tlif |
| Zimmer Biomet Holdings, INC. | $320.12 | 2024-2025 | Comprehensive Shoulder System |
| Vb Spine LLC | $287.19 | 2025 | Monterey Al, Everest Spinal System |
| Bioventus LLC | $149.86 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Stryker Corporation | $130.65 | 2025 | Hoffmann |
| Biocomposites INC | $37.22 | 2025 | Stimulan |
| Alphatec Spine, INC | $26.81 | 2025 | Invictus Open |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.